Is Coating Place, LLC FDA approved?

Coating Place, LLC holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are Coating Place, LLC's drugs manufactured?

The FDA register lists Verona, WI. Registered operations: analytical testing, active ingredient (API) manufacture, finished drug manufacture.

What drugs does Coating Place, LLC make?

10 products are listed under Coating Place, LLC in the openFDA NDC Directory, most often as capsule, extended release; granule; granule, delayed release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Coating Place, LLC

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 1
Active NDC listings: 10
Live patents: 0
Countries: 1
Base: United States

Authorisation

Registered operations

Analytical testing1Active ingredient (API) manufacture1Finished drug manufacture1

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
Coating Place, LLC	200 Paoli St, Verona, Wisconsin (WI) 53593, United States (USA)	Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture	2126906082809666

Catalogue

Drug listings by form and route

10 active NDC listings: 10 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 10.

Dosage form	NDCs
capsule, extended release	5
granule	3
granule, delayed release	2

Route	NDCs

Labeller name on the listing	NDCs
coating place, llc	10

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
-	Acetaminophen	granule	81842-418DRUG FOR FURTHER PROCESSING
-	Aminosalicylic Acid Granules	granule, delayed release	81842-467DRUG FOR FURTHER PROCESSING
-	Famotidine	granule	81842-604DRUG FOR FURTHER PROCESSING
-	Methylphenidate HCl	capsule, extended release	81842-049DRUG FOR FURTHER PROCESSING
-	Methylphenidate HCl	capsule, extended release	81842-149DRUG FOR FURTHER PROCESSING
-	Methylphenidate HCl	capsule, extended release	81842-249DRUG FOR FURTHER PROCESSING
-	Methylphenidate HCl	capsule, extended release	81842-349DRUG FOR FURTHER PROCESSING
-	Methylphenidate HCl	capsule, extended release	81842-749DRUG FOR FURTHER PROCESSING
-	Omeprazole	granule, delayed release	81842-791DRUG FOR FURTHER PROCESSING
-	Potassium Chloride	granule	81842-353DRUG FOR FURTHER PROCESSING

Neighbours

Registered in the same town

Sigma-Aldrich CorporationVerona, WI

Compare

Comparable companies in United States

Hahnemann Laboratories, Inc. dba Alpine Pharmaceuticals1 site · 4,853 NDC
NuCare Pharmaceuticals,Inc.1 site · 1,393 NDC
Greer Laboratories, Inc.1 site · 1,328 NDC
ASCLEMED USA INC. DBA ENOVACHEM1 site · 789 NDC
Golden State Medical Supply Inc.1 site · 670 NDC
Rising Pharma Holdings, Inc.1 site · 532 NDC
HF Acquisition Co LLC1 site · 363 NDC
ANI Pharmaceuticals, Inc.1 site · 299 NDC
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.1 site · 273 NDC
Newton Laboratories, Inc.1 site · 271 NDC

Enquiry

Common questions

Is Coating Place, LLC FDA approved?: Coating Place, LLC holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Coating Place, LLC's drugs manufactured?: The FDA register lists Verona, WI. Registered operations: analytical testing, active ingredient (API) manufacture, finished drug manufacture.
What drugs does Coating Place, LLC make?: 10 products are listed under Coating Place, LLC in the openFDA NDC Directory, most often as capsule, extended release; granule; granule, delayed release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.